PLANREFERENCE OUTLINE

Continued Process Verification (CPV) Plan

Stage 3 CPV plan template per the FDA Process Validation Guidance (2011) lifecycle: the CQAs and CPPs monitored, sampling plan and frequency, statistical control approach and signal rules, review cadence and roles, out-of-trend response, and linkage to periodic product review.

What a template is not

A template is a document baseline to adapt inside your own quality system. SPEQ does not approve, validate, or take responsibility for what you issue from it, and using one is not evidence of compliance.

CHECKING ACCESS

Checking your Professional access…

REGULATIONS MAPPED
FDA Process Validation Guidance (2011)21 CFR Part 211ICH Q10ICH Q8(R2)
DOCUMENT TYPE
Plan
LAST UPDATED
August 2026
PURPOSE

A Stage 3 plan under the FDA Process Validation Guidance (2011) lifecycle: an ongoing programme providing continual assurance that the process remains in a state of control during routine commercial manufacture — defining what is monitored, how it is analysed statistically, who reviews it, and what happens when a signal appears.

What's Inside

✓The monitored CQA and CPP register with links to the control strategy
✓Sampling plan, frequency, and data-source definitions per parameter
✓Statistical control approach — control charts, capability metrics, and defined signal rules
✓Data review cadence with named roles and escalation paths
✓Response procedure for out-of-trend and out-of-control results
✓Linkage to periodic product review and to change control
✓Plan approval and periodic revision sign-off

How to Use It

1Derive the monitored parameter set from the control strategy and Stage 1/Stage 2 knowledge, recording the rationale for inclusion and exclusion
2Define the sampling plan and data source for each parameter, including who enters the data and where it lives
3Select control-chart types and signal rules per parameter and document the statistical justification
4Set the review cadence and assign named roles for data review, trending interpretation, and escalation
5Define the graded response to out-of-trend versus out-of-control results and connect confirmed signals to the deviation and change-control systems
DOCUMENT CONTENTS

The full section structure of this template — every section and sub-section, so you can use it as a baseline for your own site document.

—Document Control
› Document Information› Approval Signatures› Revision History› Distribution List
1Purpose and Scope
2CQAs and CPPs Monitored
3Sampling Plan and Frequency
4Statistical Control Approach and Signals
5Data Review Cadence and Roles
6Response to Out-of-Trend and Out-of-Control Results
7Linkage to Periodic Review and Change Control
8Approval and Sign-Off
REGULATORY CONTEXT

The FDA Process Validation Guidance (2011) defines Stage 3 — continued process verification — as ongoing assurance that the process remains in a state of control, and 21 CFR Part 211 requires review of production data. ICH Q10 supplies the process performance and product quality monitoring system this plan operationalises, with CQA/CPP framing from ICH Q8(R2).

MAPPED STANDARDS
FDA Process Validation Guidance (2011)21 CFR Part 211ICH Q10ICH Q8(R2)
Browse the standards catalog →

Where to next

All 112 SPEQ templates →Filter the library by document type, product area, and format.